ST
Stereotaxis, Inc.
STXS · AMEX
$1.32 +1.15% (+$0.02)
1M -9.59%
Market Cap $128.8M
P/E Ratio -
Div. Yield -
ROE 132.62%
Piotroski F-Score Weak
3/9Valuation
25 /100
Expensive P/B 7.37x
P/S 4.28x
EV/EBITDA N/A
Growth
34 /100
Stable Book val. growth 16.30%
Rev. growth 4.78%
FCF growth N/A
Profitability
20 /100
Weak Net margin 74.24%
Op. margin 73.02%
FCF margin 51.56%
Quality
7 /100
Poor ROE 132.62%
ROA 40.16%
Asset turnover 0.54x
Debt
89 /100
Low Current ratio 1.42x
Debt/Equity 0.30x
Net debt/EBITDA N/A
Stability
64 /100
Moderate Rev. volatility 13.24%
EPS volatility 14.41%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre STXS
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
David L. Fischel
Employees
131
Headquarters
St. Louis
Evenimente viitoare
10 NOV.
Earnings
Upcoming earnings report